title: Brain-derived neurotrophic factor expression is repressed during myogenic differentiation by miR-206.
abstract: Brain-derived neurotrophic factor (BDNF) is required for efficient skeletal-muscle regeneration and perturbing its expression causes abnormalities in the proliferation and differentiation of skeletal muscle cells. In this study, we investigated the mechanism of BDNF suppression that occurs during myogenic differentiation. BDNF is expressed at the mRNA level as two isoforms that differ in the length of their 3'UTRs as a result of alternative cleavage and polyadenylation. Sequence analysis revealed the presence of three miR-206 target sites in the long BDNF 3'UTR (BDNF-L), whereas only one site was found in the short mRNA BDNF 3'UTR (BDNF-S). miR-206 is known to regulate the differentiation of C2C12 myoblasts and its expression is induced during the transition from myoblasts to myotubes. We thus examined whether miR-206-mediated suppression is responsible for the expression pattern of BDNF during myogenic differentiation. BDNF-L was suppressed to a greater extent than BDNF-S during differentiation of C2C12 myoblasts. Transfection of a miR-206 precursor decreased activity of reporters representative of the BDNF-L 3'UTR, but not BDNF-S 3'UTR, and repressed endogenous BDNF mRNA levels. This suppression was found to be dependent on the presence of multiple miR-206 target sites in the BDNF-L 3'UTR. Conversely, suppression of miR-206 levels resulted in de-repression of BDNF 3'UTR reporter activity and increased endogenous BDNF-L mRNA levels. A receptor for BDNF, p75(NTR) , was also suppressed during differentiation and in response to miR-206, but this appeared to not be entirely mediated via a miR-206 target site its 3'UTR. Based on these observations, BDNF represents a novel target through which miR-206 controls the initiation and maintenance of the differentiated state of muscle cells. These results further suggest that miR-206 might play a role in regulating retrograde signaling of BDNF at the neuromuscular junction.
authors.affiliation: Department of Cellular & Molecular Medicine and Center for Neuromuscular Disease, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
authors.forename: Pedro
authors.initials: P
authors.lastname: Miura
authors.forename: Adel
authors.initials: A
authors.lastname: Amirouche
authors.forename: Charlene
authors.initials: C
authors.lastname: Clow
authors.forename: Guy
authors.initials: G
authors.lastname: Bélanger
authors.forename: Bernard J
authors.initials: BJ
authors.lastname: Jasmin
mesh_terms: D020413:3' Untranslated Regions / Q000502:physiology; D000818:Animals; D019208:Brain-Derived Neurotrophic Factor / Q000235:genetics / Q000378:metabolism*; D002454:Cell Differentiation / Q000235:genetics / Q000502:physiology*; D002461:Cell Line, Transformed; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005786:Gene Expression Regulation / Q000502:physiology*; D051379:Mice; D035683:MicroRNAs / Q000502:physiology*; D024510:Muscle Development / Q000502:physiology*; D009154:Mutation / Q000235:genetics; D032446:Myoblasts / Q000502:physiology; D059368:RNA Isoforms / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D020800:Receptor, Nerve Growth Factor / Q000235:genetics / Q000378:metabolism; D014162:Transfection
chemical_list: D020413:3' Untranslated Regions; D019208:Brain-Derived Neurotrophic Factor; D004791:Enzyme Inhibitors; D035683:MicroRNAs; C540669:Mirn206 microRNA, mouse; D059368:RNA Isoforms; D012333:RNA, Messenger; D020800:Receptor, Nerve Growth Factor; C019277:brain-derived growth factor